Embecta Corp. (EMBC) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Embecta Corp. (EMBC:NASDAQ), powered by AI.

Current Price
$3.90
P/E Ratio
2.4
Market Cap
227M
Sector
Healthcare
What is the Embecta Corp. stock price forecast?

Embecta Corp. is currently trading at $3.90. View real-time AI analysis on Alpha Lenz.

What is Embecta Corp. insider trading activity?

View the latest insider trading data for Embecta Corp. on Alpha Lenz.

What is Embecta Corp.'s P/E ratio?

Embecta Corp.'s P/E ratio is 2.4.

Embecta Corp.

NASDAQ · EMBC
$3.90
Ask about Embecta Corp.'s future dividend policy...
Alpha Chat Insight

Embecta Corp. trades at a P/E of 2.4 (undervalued) with modest ROE of -13.7%. Operating margin of 27.4% indicates strong profitability.

Ask for details

Company Overview

Embecta Corporation is a dynamic player in the healthcare industry, primarily focused on producing advanced medical devices. Its chief function is to innovate and manufacture devices related to diabetes care, addressing both individual and clinical needs. The corporation plays a crucial role in providing solutions that facilitate the management of diabetes, which is a growing global health concern. Embecta's products are characterized by their reliability and ease of use, significantly impacting the quality of life for patients and assisting healthcare providers in delivering efficient diabetes management. With a strong emphasis on research and development, Embecta Corporation aims to address the ever-evolving medical necessities associated with diabetes. The company operates globally, ensuring broad access to its innovative medical solutions, thereby positioning itself as a vital contributor to the advancement of healthcare technologies and patient care. Through its continued dedication to excellence and innovation, Embecta Corporation holds significant market relevance, serving both individual customers and larger healthcare systems worldwide.

CEOMr. Devdatt Kurdikar Ph.D.
SectorHealthcare
IndustryMedical Instruments & Supplies
Employees2,100

Company Statistics

FY 2025

Profile

$226.87MMarket Cap
$1.08BRevenue
0.00Shares Out
2,100Employees

Margins

62.64%Gross
31.34%EBITDA
27.43%Operating
12.62%Pre-Tax
8.83%Net

Valuation

2.38P/E
-0.35P/B
0.21EV/Sales
4.23EV/EBITDA
1.24P/FCF

Growth (CAGR)

-1.47%Rev 3Yr
-0.09%Rev 5Yr
-7.00%Op Inc 3Yr
-9.44%Op Inc 5Yr
-24.72%Net Inc 3Yr
-25.92%Net Inc 5Yr

Returns

8.03%ROA
-13.73%ROE
20.50%ROIC

Financial Health

$225.50MCash & Cash Equivalents
$1.52BNet Debt
-267.52%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Embecta Corp. (ticker: EMBC) is a company listed on NASDAQ in the Healthcare sector (Medical Instruments & Supplies). It has approximately 2,100 employees. Market cap is $227M.

The current price is $3.9 with a P/E ratio of 2.38x and P/B of -0.35x.

ROE is -13.73% and operating margin is 27.43%. Annual revenue is $1.1B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Embecta Corp. (Healthcare) Stock Forecast & Analysis $3.90 | Alpha Lenz